VAMYLIO Trademark
VAMYLIO is a USPTO trademark filed by Prothena Biosciences Limited. Status: Registered.
Trademark Facts
| Mark | VAMYLIO |
|---|---|
| Serial Number | 79392815 |
| Registration Number | 7583218 |
| Status | Registered |
| Filing Date | 2024-02-02 |
| Registration Date | 2024-12-03 |
| Mark Type | Stylized |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT), 045 (Legal Services) |
| Owner | Prothena Biosciences Limited |
| Prosecution Events | 13 |
| Latest Event | OPNX on 2025-09-19 |
Goods & Services
Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes; Licensing of intellectual property in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields